These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 22051092

  • 1. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF, Ragi-Eis S, Vieira NF, Soprani M, Neves MB, Ribeiro-Rodrigues R, Miranda AE.
    J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Jan 30; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 4. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
    Patel R, Blake GM, Fogelman I.
    Calcif Tissue Int; 2007 Feb 30; 80(2):89-96. PubMed ID: 17308990
    [Abstract] [Full Text] [Related]

  • 5. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E, Castagna A, Soldarini A, Galli L, Fusetti G, Dorigatti F, Hasson H, Danise A, Guffanti M, Lazzarin A, Rubinacci A.
    HIV Med; 2005 May 30; 6(3):145-50. PubMed ID: 15876279
    [Abstract] [Full Text] [Related]

  • 6. Low bone mineral density among HIV-infected patients in Brazil.
    Chaba DCDS, Soares LR, Pereira RMR, Rutherford GW, Assone T, Takayama L, Fonseca LAM, Duarte AJS, Casseb J.
    Rev Inst Med Trop Sao Paulo; 2017 Dec 21; 59():e89. PubMed ID: 29267597
    [Abstract] [Full Text] [Related]

  • 7. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug 21; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 8. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec 21; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 9. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
    Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A.
    J Infect Dis; 2009 Dec 01; 200(11):1746-54. PubMed ID: 19874178
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors.
    Souto MI, Coelho A, Guo C, Mendonça LM, Pinheiro MF, Papi JA, Farias ML.
    J Clin Densitom; 2012 Dec 01; 15(3):320-7. PubMed ID: 22321657
    [Abstract] [Full Text] [Related]

  • 11. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
    Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J.
    J Clin Endocrinol Metab; 2004 Mar 01; 89(3):1200-6. PubMed ID: 15001610
    [Abstract] [Full Text] [Related]

  • 12. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 01; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.
    Arthritis Rheum; 2007 Jun 01; 56(6):1966-73. PubMed ID: 17530722
    [Abstract] [Full Text] [Related]

  • 15. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.
    AIDS; 2007 Nov 30; 21(18):2473-82. PubMed ID: 18025884
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.
    HIV Med; 2015 Apr 30; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
    [Abstract] [Full Text] [Related]

  • 17. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS, Hung CC, Liu WC, Chen KL, Chen MY, Hsieh SM, Sheng WH, Sun HY, Shih TT.
    J Microbiol Immunol Infect; 2014 Apr 30; 47(2):109-15. PubMed ID: 23073318
    [Abstract] [Full Text] [Related]

  • 18. Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors.
    Gomes DC, Valadares AL, de Moraes MJ, Lagrutta BB, Pinto-Neto AM, Costa-Paiva L.
    Menopause; 2015 Feb 30; 22(2):224-30. PubMed ID: 25003619
    [Abstract] [Full Text] [Related]

  • 19. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
    Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D, ANRS 121 Hippocampe study group.
    AIDS; 2009 Apr 27; 23(7):817-24. PubMed ID: 19363330
    [Abstract] [Full Text] [Related]

  • 20. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
    Delpierre C, Bonnet E, Marion-Latard F, Aquilina C, Obadia M, Marchou B, Massip P, Perret B, Bernard J.
    J Clin Densitom; 2007 Apr 27; 10(4):376-80. PubMed ID: 17888698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.